Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The book explains how excess male hormones can affect various conditions like Polycystic Ovary Syndrome and Cushing's disease.

Finasteride may improve prostate cancer treatment outcomes.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Finasteride helps treat hair loss by blocking enzyme activity.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Finasteride side effects in young men may be linked to specific gene variations.